News
Scientists developed a groundbreaking antivenom cocktail using antibodies from a hyperimmune human donor and a small-molecule ...
A study from the ORIGINS cohort in Western Australia assessed the diets of one-year-old children, comparing intake to ...
Researchers in Japan found that estrogen produced within the brain, called neuroestrogen, suppresses appetite and reduces ...
The country's top nonpartisan government watchdog has confirmed it is examining the costs of running the nation's only active ...
Protein is essential for health, influencing muscle maintenance, recovery, and overall function. Understand your unique ...
A study using artificial intelligence to classify patient pain archetypes and identify risk for severe pain after knee ...
A new research paper was published in Aging (Aging-US) on April 2, 2025, as the cover of Volume 17, Issue 4, titled "Decreased mitochondrial NAD+ in WRN deficient cells links to dysfunctional ...
The first study evaluating Medicare patients undergoing percutaneous coronary intervention (PCI) in ambulatory surgery centers (ASCs) demonstrated good safety outcomes, such as mortality and adverse ...
New clinical results from multiple studies show coronary heart disease death associated with tobacco use is anticipated to rise up to 40% in the next five years and people with cannabis use disorder ...
Faced with potential federal spending cuts that threaten health coverage and falling childhood vaccination rates, Monica Soni, the chief medical officer of Covered California, has a lot on her plate — ...
Study data reveal how a specific sequence of cancer therapies can improve outcomes for patients with hard-to-treat lymphomas.
Plasma-activated medium (PAM) shows tumor-fighting effects against the rare form of cancer known as synovial sarcoma, an Osaka Metropolitan University-led research team has found.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results